← Leaderboards
Philip Zachary Mannes
University Of Pittsburgh At Pittsburgh
$209,256
Attributed
$209,256
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$209,256 · 1
By mechanism
F30$209,256 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- William E Klunk$26,129,826
- Benjamin L Handen$48,952,794
- Sina Tavakoli$3,298,420
- Paul E Kinahan$18,562,598
- Joanne L. Flynn$43,717,509
Others in their field
Other Emerging Leaders on “Dendritic Cells”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Gary Fanger · Rise Therapeutics, Llc$11,457,164
- Norbert Pardi · University Of Pennsylvania$9,130,651
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
- Dawn C Ward · University Of California Los Angeles$7,282,377
- Kevin Wiehe · Duke University$7,046,198
Research focus
Dendritic CellsClinical PracticeCmklr1 GeneC-TerminalAcuteAlveolarAcute Lung InjuryAsthmaComplexCritical IllnessAgonistBiochemicalBiologicalBiological MarkersBiopsyBronchoalveolar LavageCell MotilityCellsAutomobile DrivingChemokine ReceptorChemotactic FactorsAffinityBindingDesign
Grant awards (4)
Molecular Imaging of the ChemR23-Chemerin Axis in Acute Lung Injury$53,974
F30 · FY2024 · HL · contact PI
Molecular Imaging of the ChemR23-Chemerin Axis in Acute Lung Injury$52,694
F30 · FY2023 · HL · contact PI
Molecular Imaging of the ChemR23-Chemerin Axis in Acute Lung Injury$51,552
F30 · FY2022 · HL · contact PI
Molecular Imaging of the ChemR23-Chemerin Axis in Acute Lung Injury$51,036
F30 · FY2021 · HL · contact PI